Newton (formerly Neurolens) announced a strategic partnership with Hong Kong Optical Lens Co (HKO) as the exclusive distributor for Hong Kong and China, bringing the therapeutic solutions of Neurolens and Sequel lenses to millions across two of the world's most digitally connected markets.

Newton’s expansion into Hong Kong is supported by HKO's strategic partner CMER Eye Centers, which has integrated the Neurolens N3 measurement device into its practice. In support of advancing eye care education, HKO, together with Newton, have donated N3 devices to The Hong Kong Polytechnic University School of Optometry, enabling future eye care professionals to train on this innovative technology.

The N3 diagnostic device provides objective measurement of eye misalignment. Neurolens therapeutic lenses use patented Contoured Prism technology to alleviate visual misalignments leading to headaches, neck pain, motion sickness, and eye strain, delivering relief for up to 90% of symptomatic patients.

The Sequel everyday lens is designed for daily wear to prevent and alleviate digital eye strain, and its proprietary Convergence Boost technology provides comfortable vision for extended screen time.

"This partnership marks a pivotal moment in Newton's global expansion," said Davis Corley, Newton CEO. "Hong Kong Optical Lens' market expertise positions us to bring relief to millions experiencing headaches, neck pain, motion sickness, and digital eye strain. This is just the beginning of Newton's international growth."

Eddie So, Managing Director of Hong Kong Optical Lens, added, "Our legacy is rooted in a partner-first philosophy, working closely with global brands, to transform market insights into reality. We are excited to partner with Newton to bring the cutting-edge Neurolens and Sequel technologies to Hong Kong and China."